Stockreport

Zai Lab's Growth Strategy And China's Policy Reforms Set Path For Profitability By 2025 [Seeking Alpha]

Zai Lab Limited - American Depositary Shares  (ZLAB) 
US:NASDAQ Investor Relations: zailaboratory.com/about/investors.php
PDF Follow Play 16min Summary Zai Lab Limited leverages global partnerships to commercialize approved therapies in China, focusing on oncology, autoimmune, infectio [Read more]